Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
Kidney patients are often given anemia medication, but new findings suggest that it may do very little to improve their well-being. The anemia drugs are called erythropoietin-stimulating agents (ESAs), and the findings work to back up the current implemented guidelines on using ESAs.
Senior researcher Dr. Navdeep Tangri said, patients may still benefit from the medications as they reduce the need for blood transfusions, but added, “This should close the book on the idea that these drugs help with exhaustion and improve patients’ quality of life.”